Guest guest Posted December 14, 2007 Report Share Posted December 14, 2007 LRF_CancerCare - Post ASH Teleconference Tues. Dec. 18, 07Greetings, Brought to you by LRF and others. Dr. Press gave an excellent presentation last year! ~ Karl == Update on Lymphoma Treatment from the 2007 American Society of Hematology (ASH) Annual Meeting On Tuesday, December 18, 2007 from 1:30pm – 2:30pm EST, the Lymphoma Research Foundation (LRF) and CancerCare will bring together a distinguished panel of researchers and clinicians for a lymphoma teleconference entitled Update on Lymphoma Treatment from the 2007 American Society of Hematology (ASH) Annual Meeting. This program is made possible by an unrestricted educational grant to LRF from GlaxoKline and TWO EASY WAYS TO REGISTER Phone: 800-813-4673 Web: Click Here http://tinyurl.com/2my4vh Friends of CancerCare. Program Faculty Oliver W. Press, MD, PhD Member, The Fred Hutchinson Cancer Research Center, Recipient, Dr. Penny E. sen Memorial Chair for Lymphoma Research, Professor of Medicine and Biological Structure, University of Washington, Director, Clinical Research in Hematology & Hematologic Malignancies, Seattle Cancer Care Alliance Mills, LMSW, MPH National Director, Patient Programs, Lymphoma Research Foundation Dickens, MSW Blood Cancers Program Coordinator, Project Coordinator, Mind/Body Program, CancerCare Topics Will Include • Brief Overview of Current Treatments for Lymphoma • New Research Findings Presented at ASH • How Research Influences Treatment Options • Disease-Specific Treatment Updates • Clinical Trials • Symptom and Pain Management • Communicating with Your Healthcare Team • Questions for Our Panel of Experts Registration Instructions This program is offered free-of-charge, however, pre-registration is required. After you have registered, you will receive additional information from CancerCare. TWO EASY WAYS TO REGISTER Phone: 800-813-4673 Web: Click Here http://tinyurl.com/2my4vh Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.